130.48  1.17 (0.9%)		06-12 16:00
Open: 128.82 High: 132.24 Volume: 334,450		Pre. Close: 129.31 Low: 127.61 Market Cap: 5,776(M)

Short term
Mid term
Targets	6-month :	154.13	1-year :	159.53
Resists	First :	131.96	Second :	136.58
Pivot price	130.38
Supports	First :	124.48	Second :	103.57
MAs	MA(5) :	131.88	MA(20) :	130.69
	MA(100) :	118.87	MA(250) :	119.13
MACD	MACD :	0.9	Signal :	1.1
%K %D	K(14,3) :	50.8	D(3) :	64.3
RSI	RSI(14): 51.3
52-week	High :	139.3	Low :	99.63

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ TFX ] has closed below upper band by 49.0%. Bollinger Bands are 45.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	132.31 - 132.96	132.96 - 133.62
Low:	126.1 - 126.76	126.76 - 127.44
Close:	129.4 - 130.46	130.46 - 131.55

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

Thu, 11 Jun 2026
Will Teleflex's (TFX) Note Refinancing and Freesolve Data Shift Its Acquisition-Led Innovation Narrative? - simplywall.st

Tue, 09 Jun 2026
Teleflex Inc (TFX) Stock Up 3.0% and Still Undervalued -- GF Sco - GuruFocus

Tue, 09 Jun 2026
[Form 3] TELEFLEX INC Initial Statement of Beneficial Ownership - Stock Titan

Tue, 09 Jun 2026
Teleflex (TFX) CEO Jason Weidman receives new RSU and stock option grants - Stock Titan

Tue, 09 Jun 2026
Teleflex unveils four-year data for Freesolve medical scaffold - grafa.com

Sun, 07 Jun 2026
TFX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	44 (M)
Shares Float	44 (M)
Held by Insiders	0.4 (%)
Held by Institutions	110.7 (%)
Shares Short	2,380 (K)
Shares Short P.Month	2,430 (K)

EPS	0.05
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	69.68
Profit Margin	-47.5 %
Operating Margin	8.3 %
Return on Assets (ttm)	2.3 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	32.2 %
Gross Profit (p.s.)	26.65
Sales Per Share	48.11
EBITDA (p.s.)	10.23
Qtrly Earnings Growth	0 %
Operating Cash Flow	317 (M)
Levered Free Cash Flow	-4 (M)

PE Ratio	2174.66
PEG Ratio	0.1
Price to Book value	1.87
Price to Sales	2.71
Price to Cash Flow	18.24

Dividend	0.34
Forward Dividend	0
Dividend Yield	0.2%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.